Bipolar Research Today is a free monthly online journal that collates and summarizes the latest research about Bipolar, including details on bipolar disorder, symptoms, treatment, depression, medication.

Volume 8 (2011), Issue 2 (February)

1. Informing the symptom profile of complicated grief.
   Depress Anxiety, 28(2): 118-26. [Abstract] [Full-text]
2. Psychopharmacology of pediatric bipolar disorders in children and adolescents.
   Pediatr Clin North Am, 58(1): 173-87. [Abstract] [Full-text]
3. Decreased BDNF, trkB-TK+ and GAD(67) mRNA expression in the hippocampus of individuals with schizophrenia and mood disorders.
   J Psychiatry Neurosci, 36(1): 100048. [Abstract] [Full-text]
4. Decreased self-reported arousal in schizophrenia during aversive picture viewing compared to bipolar disorder and healthy controls.
   Psychiatry Res, 185(3): 309-14. [Abstract] [Full-text]
5. Ecologically valid support for the link between cognitive and psychosocial functioning in bipolar disorder.
   Psychiatry Res, 185(3): 353-7. [Abstract] [Full-text]
6. Cannabis involvement in individuals with bipolar disorder.
   Psychiatry Res, 185(3): 459-61. [Abstract] [Full-text]
7. Psychiatric diagnoses in patients who screen positive on the Mood Disorder Questionnaire: Implications for using the scale as a case-finding instrument for bipolar disorder.
   Psychiatry Res, 185(3): 444-9. [Abstract] [Full-text]
8. Intron 12 in NTRK3 is associated with bipolar disorder.
   Psychiatry Res, 185(3): 358-62. [Abstract] [Full-text]
9. Decreased self-reported arousal in schizophrenia during aversive picture viewing compared to bipolar disorder and healthy controls.
   Psychiatry Res, 185(3): 309-14. [Abstract] [Full-text]
10. Ecologically valid support for the link between cognitive and psychosocial functioning in bipolar disorder.
    Psychiatry Res, 185(3): 353-7. [Abstract] [Full-text]
11. Cannabis involvement in individuals with bipolar disorder.
    Psychiatry Res, 185(3): 459-61. [Abstract] [Full-text]
12. Psychiatric diagnoses in patients who screen positive on the Mood Disorder Questionnaire: Implications for using the scale as a case-finding instrument for bipolar disorder.
    Psychiatry Res, 185(3): 444-9. [Abstract] [Full-text]
13. Intron 12 in NTRK3 is associated with bipolar disorder.
    Psychiatry Res, 185(3): 358-62. [Abstract] [Full-text]
14. Obsessive-compulsive disorder in the community: 12-month prevalence, comorbidity and impairment.
    Soc Psychiatry Psychiatr Epidemiol. [Abstract] [Full-text]
15. After GWAS: Searching for Genetic Risk for Schizophrenia and Bipolar Disorder.
    Am J Psychiatry. [Abstract] [Full-text]
16. Investigation of Cortical Thickness Abnormalities in Lithium-Free Adults With Bipolar I Disorder Using Cortical Pattern Matching.
    Am J Psychiatry. [Abstract] [Full-text]
17. Association between prior authorization for medications and health service use by medicaid patients with bipolar disorder.
    Psychiatr Serv, 62(2): 186-93. [Abstract] [Full-text]
18. Combined analysis of grey matter voxel-based morphometry and white matter tract-based spatial statistics in late-life bipolar disorder.
    J Psychiatry Neurosci, 36(1): 100140. [Abstract] [Full-text]
19. Exome localization of complex disease association signals.
    BMC Genomics, 12(1): 92. [Abstract] [Full-text]
20. Schizoaffective Disorder: A Review of Current Research Themes and Pharmacological Management.
    CNS Drugs. [Abstract] [Full-text]
21. Suicidality and divalproex sodium: analysis of controlled studies in multiple indications.
    Ann Gen Psychiatry, 10(1): 1. [Abstract] [Full-text]
22. Biological aspect of hyperthymic temperament: light, sleep, and serotonin.
    Psychopharmacology (Berl), 213(2): 633-8. [Abstract] [Full-text]
23. Metformin for olanzapine-induced weight gain: a systematic review and meta-analysis.
    Br J Clin Pharmacol, 71(3): 377-82. [Abstract] [Full-text]
24. Treatments for bipolar disorder: can number needed to treat/harm help inform clinical decisions?
    Acta Psychiatr Scand, 123(3): 175-89. [Abstract] [Full-text]
25. Meta-analytic review of neurocognition in bipolar II disorder.
    Acta Psychiatr Scand, 123(3): 165-74. [Abstract] [Full-text]
26. A 2-year naturalistic study on cognitive functioning in bipolar disorder.
    Acta Psychiatr Scand, 123(3): 190-205. [Abstract] [Full-text]
27. Depressive and manic symptoms are not opposite poles in bipolar disorder.
    Acta Psychiatr Scand, 123(3): 206-10. [Abstract] [Full-text]
28. Metformin for olanzapine-induced weight gain: a systematic review and meta-analysis.
    Br J Clin Pharmacol, 71(3): 377-82. [Abstract] [Full-text]
29. Treatments for bipolar disorder: can number needed to treat/harm help inform clinical decisions?
    Acta Psychiatr Scand, 123(3): 175-89. [Abstract] [Full-text]
30. Meta-analytic review of neurocognition in bipolar II disorder.
    Acta Psychiatr Scand, 123(3): 165-74. [Abstract] [Full-text]
31. A 2-year naturalistic study on cognitive functioning in bipolar disorder.
    Acta Psychiatr Scand, 123(3): 190-205. [Abstract] [Full-text]
32. Depressive and manic symptoms are not opposite poles in bipolar disorder.
    Acta Psychiatr Scand, 123(3): 206-10. [Abstract] [Full-text]
33. Transient receptor potential genes and human inherited disease.
    Adv Exp Med Biol, 704: 1011-32. [Abstract] [Full-text]
34. Parent of origin effect and allelic expression imbalance of the serotonin transporter in bipolar disorder and suicidal behaviour.
    Eur Arch Psychiatry Clin Neurosci. [Abstract] [Full-text]
35. When should mood stabilizers be withdrawn due to lack of efficacy? Some methodological considerations.
    Eur Psychiatry. [Abstract] [Full-text]
36. Parent of origin effect and differential allelic expression of BDNF Val66Met in suicidal behaviour.
    World J Biol Psychiatry, 12(1): 42-7. [Abstract] [Full-text]
37. Unrecognised bipolar disorder in primary care patients with depression.
    Br J Psychiatry. [Abstract] [Full-text]
38. Age at onset in bipolar disorder: Investigation of the role of TaqIA polymorphism of DRD2 gene in a Sardinian sample.
    Eur Psychiatry. [Abstract] [Full-text]
39. Initial evidence for the role of CACNA1C on subcortical brain morphology in patients with bipolar disorder.
    Eur Psychiatry. [Abstract] [Full-text]
40. Baseline and prodromal characteristics of first- versus multiple-episode mania in a French cohort of bipolar patients.
    Eur Psychiatry. [Abstract] [Full-text]
41. The effects of centralised and specialised combined pharmacological and psychological intervention compared with decentralised and non-specialised treatment in the early course of severe unipolar and bipolar affective disorders - design of two randomised clinical trials.
    Trials, 12(1): 32. [Abstract] [Full-text]
42. Evidence for somatic gene conversion and deletion in bipo- lar disorder, Crohn's disease, coronary artery disease, hyper- tension, rheumatoid arthritis, type-1 diabetes, and type-2 diabetes.
    BMC Med, 9(1): 12. [Abstract] [Full-text]
43. Number needed to treat analyses of drugs used for maintenance treatment of bipolar disorder.
    Psychopharmacology (Berl), 213(4): 657-67. [Abstract] [Full-text]
44. Valproate uncompetitively inhibits arachidonic acid acylation by rat acyl-CoA synthetase 4: relevance to valproate's efficacy against bipolar disorder.
    Biochim Biophys Acta, 1811(3): 163-9. [Abstract] [Full-text]
45. Valproate uncompetitively inhibits arachidonic acid acylation by rat acyl-CoA synthetase 4: relevance to valproate's efficacy against bipolar disorder.
    Biochim Biophys Acta, 1811(3): 163-9. [Abstract] [Full-text]
46. Co-occurring manic symptomatology as a dimension which may help explaining heterogeneity of depression.
    J Affect Disord. [Abstract] [Full-text]
47. Effects of atypical antipsychotics on neurocognition in euthymic bipolar patients.
    Compr Psychiatry. [Abstract] [Full-text]
48. Effectiveness and safety of vagus nerve stimulation for severe treatment-resistant major depression in clinical practice after FDA approval: outcomes at 1 year.
    J Clin Psychiatry. [Abstract] [Full-text]
49. Increased olanzapine discontinuation and health care resource utilization following a medicaid policy change.
    J Clin Psychiatry. [Abstract] [Full-text]
50. Quality of reporting of randomized controlled trials of pharmacologic treatment of bipolar disorders: a systematic review.
    J Clin Psychiatry. [Abstract] [Full-text]
51. Lithium Fails to Protect Dopaminergic Neurons in the 6-OHDA Model of Parkinson's Disease.
    Neurochem Res, 36(3): 367-74. [Abstract] [Full-text]
52. Between destiny and disease: Genetics and molecular pathways of human central nervous system aging.
    Prog Neurobiol, 93(2): 165-81. [Abstract] [Full-text]
53. Severe mood dysregulation, irritability, and the diagnostic boundaries of bipolar disorder in youths.
    Am J Psychiatry, 168(2): 129-42. [Abstract] [Full-text]
54. Patterns of salivary cortisol secretion and responses to daily events in patients with remitted bipolar disorder.
    Psychoneuroendocrinology, 36(2): 258-65. [Abstract] [Full-text]
55. Recognizing mania in children and adolescents-age does not matter, but decreased need for sleep does.
    Compr Psychiatry, 52(2): 132-8. [Abstract] [Full-text]
56. Diagnostic and prognostic significance of Schneiderian first-rank symptoms: a 20-year longitudinal study of schizophrenia and bipolar disorder.
    Compr Psychiatry, 52(2): 126-31. [Abstract] [Full-text]
57. Lithium fails to protect dopaminergic neurons in the 6-OHDA model of Parkinson's disease.
    Neurochem Res, 36(3): 367-74. [Abstract] [Full-text]
58. Recognizing mania in children and adolescents-age does not matter, but decreased need for sleep does.
    Compr Psychiatry, 52(2): 132-8. [Abstract] [Full-text]
59. Diagnostic and prognostic significance of Schneiderian first-rank symptoms: a 20-year longitudinal study of schizophrenia and bipolar disorder.
    Compr Psychiatry, 52(2): 126-31. [Abstract] [Full-text]
60. Lithium fails to protect dopaminergic neurons in the 6-OHDA model of Parkinson's disease.
    Neurochem Res, 36(3): 367-74. [Abstract] [Full-text]
61. Genetic association and sequencing of the insulin-like growth factor 1 gene in bipolar affective disorder.
    Am J Med Genet B Neuropsychiatr Genet, 156(2): 177-87. [Abstract] [Full-text]
62. Does telomere length mediate associations between inbreeding and increased risk for bipolar I disorder and schizophrenia?
    Psychiatry Res. [Abstract] [Full-text]
63. Performance-based assessment of functional skills in severe mental illness: Results of a large-scale study in China.
    J Psychiatr Res. [Abstract] [Full-text]
64. Effect of mental health courts on arrests and jail days: a multisite study.
    Arch Gen Psychiatry, 68(2): 167-72. [Abstract] [Full-text]
65. Evaluation of risk loci for schizophrenia derived from genome-wide association studies in a German population.
    Am J Med Genet B Neuropsychiatr Genet, 156(2): 198-203. [Abstract] [Full-text]
66. Genetic association and sequencing of the insulin-like growth factor 1 gene in bipolar affective disorder.
    Am J Med Genet B Neuropsychiatr Genet, 156(2): 177-87. [Abstract] [Full-text]
67. Fine mapping of candidate regions for bipolar disorder provides strong evidence for susceptibility loci on chromosomes 7q.
    Am J Med Genet B Neuropsychiatr Genet, 156(2): 168-76. [Abstract] [Full-text]
68. Does telomere length mediate associations between inbreeding and increased risk for bipolar I disorder and schizophrenia?
    Psychiatry Res. [Abstract] [Full-text]
69. Evaluation of risk loci for schizophrenia derived from genome-wide association studies in a German population.
    Am J Med Genet B Neuropsychiatr Genet, 156(2): 198-203. [Abstract] [Full-text]
70. Genetic association and sequencing of the insulin-like growth factor 1 gene in bipolar affective disorder.
    Am J Med Genet B Neuropsychiatr Genet, 156(2): 177-87. [Abstract] [Full-text]
71. Fine mapping of candidate regions for bipolar disorder provides strong evidence for susceptibility loci on chromosomes 7q.
    Am J Med Genet B Neuropsychiatr Genet, 156(2): 168-76. [Abstract] [Full-text]
72. Genome-wide association analysis of age at onset and psychotic symptoms in bipolar disorder.
    Am J Med Genet B Neuropsychiatr Genet. [Abstract] [Full-text]
73. Dysbindin-1 gene contributes differentially to early- and adult-onset forms of functional psychosis.
    Am J Med Genet B Neuropsychiatr Genet. [Abstract] [Full-text]
74. The Cognitive Impact of the ANK3 Risk Variant for Bipolar Disorder: Initial Evidence of Selectivity to Signal Detection during Sustained Attention.
    PLoS One, 6(1): e16671. [Abstract] [Full-text]
75. The Physiology, Signaling, and Pharmacology of Dopamine Receptors.
    Pharmacol Rev. [Abstract] [Full-text]
76. Deficits in GABA(B) receptor system in schizophrenia and mood disorders: A postmortem study.
    Schizophr Res. [Abstract] [Full-text]
77. Genome-wide association analysis of age at onset and psychotic symptoms in bipolar disorder.
    Am J Med Genet B Neuropsychiatr Genet. [Abstract] [Full-text]
78. Dysbindin-1 gene contributes differentially to early- and adult-onset forms of functional psychosis.
    Am J Med Genet B Neuropsychiatr Genet. [Abstract] [Full-text]
79. Deficits in GABA(B) receptor system in schizophrenia and mood disorders: A postmortem study.
    Schizophr Res. [Abstract] [Full-text]
80. The characteristics of a discrete mood episode, neuro-cognitive impairment and re-hospitalization in bipolar disorder.
    J Psychiatr Res. [Abstract] [Full-text]
81. Antidepressant-like Responses to Lithium in Genetically Diverse Mouse Strains.
    Genes Brain Behav. [Abstract] [Full-text]
82. The Prevalence of Mental Disorders in Prisoners in the City of Salvador, Bahia, Brazil*
    J Forensic Sci. [Abstract] [Full-text]
83. The Farsi version of the Hypomania Check-List 32 (HCL-32): Applicability and indication of a four-factorial solution.
    BMC Psychiatry, 11: 14. [Abstract] [Full-text]
84. One-year risk of psychiatric hospitalization and associated treatment costs in bipolar disorder treated with atypical antipsychotics: a retrospective claims database analysis.
    BMC Psychiatry, 11: 6. [Abstract] [Full-text]
85. The characteristics of a discrete mood episode, neuro-cognitive impairment and re-hospitalization in bipolar disorder.
    J Psychiatr Res. [Abstract] [Full-text]
86. The Prevalence of Mental Disorders in Prisoners in the City of Salvador, Bahia, Brazil*
    J Forensic Sci. [Abstract] [Full-text]
87. Is the Mood Disorder Questionnaire an appropriate screening tool in detecting bipolar spectrum disorder among substance use populations?
    Am J Drug Alcohol Abuse, 37(2): 79-81. [Abstract] [Full-text]
88. Risk factors for bullous pemphigoid in the elderly: a prospective case-control study.
    J Invest Dermatol, 131(3): 637-43. [Abstract] [Full-text]
89. Is the Mood Disorder Questionnaire an appropriate screening tool in detecting bipolar spectrum disorder among substance use populations?
    Am J Drug Alcohol Abuse, 37(2): 79-81. [Abstract] [Full-text]
90. Risk factors for bullous pemphigoid in the elderly: a prospective case-control study.
    J Invest Dermatol, 131(3): 637-43. [Abstract] [Full-text]
91. Is there a relationship between attention deficit/hyperactivity disorder and manic symptoms among children with mental retardation of unknown etiology?
    Compr Psychiatry. [Abstract] [Full-text]
92. A fast, powerful method for detecting identity by descent.
    Am J Hum Genet, 88(2): 173-82. [Abstract] [Full-text]
93. Mitochondria, oligodendrocytes and inflammation in bipolar disorder: Evidence from transcriptome studies points to intriguing parallels with multiple sclerosis.
    Neurobiol Dis. [Abstract] [Full-text]
94. Risk factors of attempted suicide in bipolar disorder.
    Suicide Life Threat Behav, 41(1): 6-11. [Abstract] [Full-text]
95. Tamoxifen effects on respiratory chain complexes and creatine kinase activities in an animal model of mania.
    Pharmacol Biochem Behav. [Abstract] [Full-text]
96. Serum brain-derived neurotrophic factor and clozapine daily dose in patients with schizophrenia: A positive correlation.
    Neurosci Lett. [Abstract] [Full-text]
97. Is there a relationship between attention deficit/hyperactivity disorder and manic symptoms among children with mental retardation of unknown etiology?
    Compr Psychiatry. [Abstract] [Full-text]
98. A fast, powerful method for detecting identity by descent.
    Am J Hum Genet, 88(2): 173-82. [Abstract] [Full-text]
99. Longitudinal changes in brain structure following the first episode of psychosis.
    Psychiatry Res. [Abstract] [Full-text]
100. Use of the Hypomania Checklist-32 and the Mood Disorder Questionnaire for detecting bipolarity in 1,051 patients with major depressive disorder.
     Eur Psychiatry. [Abstract] [Full-text]
101. Circadian clock gene Per3 variants influence the postpartum onset of bipolar disorder.
     Eur Psychiatry. [Abstract] [Full-text]
102. Do risk factors for schizophrenia predispose to emigration?
     Schizophr Res. [Abstract] [Full-text]
103. The impact of drug use in social networks of patients with substance use and bipolar disorders.
     Am J Addict, 20(2): 100-5. [Abstract] [Full-text]
104. Platelet GSK3B activity in patients with late-life depression: Marker of depressive episode severity and cognitive impairment?
     World J Biol Psychiatry. [Abstract] [Full-text]
105. Meta-analysis of ACE gene I/D polymorphism and bipolar disorder susceptibility.
     Nord J Psychiatry. [Abstract] [Full-text]
106. Irritability in children and adolescents: a challenge for DSM-5.
     Eur Child Adolesc Psychiatry, 20(2): 61-6. [Abstract] [Full-text]
107. Comorbidities of epilepsy: Results from the Epilepsy Comorbidities and Health (EPIC) survey.
     Epilepsia, 52(2): 308-315. [Abstract] [Full-text]
108. Managing bipolar youths in a psychiatric inpatient emergency service.
     Child Psychiatry Hum Dev, 42(1): 1-11. [Abstract] [Full-text]
109. Use of the Hypomania Checklist-32 and the Mood Disorder Questionnaire for detecting bipolarity in 1,051 patients with major depressive disorder.
     Eur Psychiatry. [Abstract] [Full-text]
110. Circadian clock gene Per3 variants influence the postpartum onset of bipolar disorder.
     Eur Psychiatry. [Abstract] [Full-text]
111. The impact of drug use in social networks of patients with substance use and bipolar disorders.
     Am J Addict, 20(2): 100-5. [Abstract] [Full-text]
112. Platelet GSK3B activity in patients with late-life depression: Marker of depressive episode severity and cognitive impairment?
     World J Biol Psychiatry. [Abstract] [Full-text]
113. Meta-analysis of ACE gene I/D polymorphism and bipolar disorder susceptibility.
     Nord J Psychiatry. [Abstract] [Full-text]
114. Irritability in children and adolescents: a challenge for DSM-5.
     Eur Child Adolesc Psychiatry, 20(2): 61-6. [Abstract] [Full-text]
115. Aerosolised antipsychotic assuages agitation: inhaled loxapine for agitation associated with schizophrenia or bipolar disorder.
     Int J Clin Pract, 65(3): 330-40. [Abstract] [Full-text]
116. CTLA-4 confers a risk of recurrent schizophrenia, major depressive disorder and bipolar disorder in the Chinese Han population.
     Brain Behav Immun, 25(3): 429-33. [Abstract] [Full-text]
117. Paliperidone extended-release as adjunctive therapy to lithium or valproate in the treatment of acute mania: a randomized, placebo-controlled study.
     J Affect Disord, 129(1): 252-60. [Abstract] [Full-text]
118. Prolidase activity and its diagnostic performance in bipolar disorder.
     J Affect Disord, 129(1): 84-6. [Abstract] [Full-text]
119. Diet quality in bipolar disorder in a population-based sample of women.
     J Affect Disord, 129(1): 332-7. [Abstract] [Full-text]
120. Self-stigma, empowerment and perceived discrimination among people with bipolar disorder or depression in 13 European countries: the GAMIAN-Europe study.
     J Affect Disord, 129(1): 56-63. [Abstract] [Full-text]
121. Binge eating disorder and menstrual cycle in unmedicated women with bipolar disorder.
     J Affect Disord, 129(1): 75-8. [Abstract] [Full-text]
122. Correlates of first-episode polarity in a French cohort of 1089 bipolar I disorder patients: role of temperaments and triggering events.
     J Affect Disord, 129(1): 39-46. [Abstract] [Full-text]
123. Double-blind, randomized, placebo-controlled 6-week study on the efficacy and safety of the tamoxifen adjunctive to lithium in acute bipolar mania.
     J Affect Disord, 129(1): 327-31. [Abstract] [Full-text]
124. Long-term naturalistic follow-up of lithium augmentation: relevance to bipolarity.
     J Affect Disord, 129(1): 64-7. [Abstract] [Full-text]
125. Bipolar disorder patients have similar levels of education but lower socio-economic status than the general population.
     J Affect Disord, 129(1): 68-74. [Abstract] [Full-text]
126. Differential outcome of bipolar patients receiving antidepressant monotherapy versus combination with an antimanic drug.
     J Affect Disord, 129(1): 321-6. [Abstract] [Full-text]
127. N-acetyl cysteine add-on treatment for bipolar II disorder: a subgroup analysis of a randomized placebo-controlled trial.
     J Affect Disord, 129(1): 317-20. [Abstract] [Full-text]
128. Association of seasonality and premenstrual symptoms in Bipolar I and Bipolar II disorders.
     J Affect Disord, 129(1): 313-6. [Abstract] [Full-text]
129. Cyclothymic and hyperthymic temperaments may predict bipolarity in major depressive disorder: a supportive evidence for bipolar II1/2 and IV.
     J Affect Disord, 129(1): 34-8. [Abstract] [Full-text]
130. New treatment guidelines for acute bipolar depression: a systematic review.
     J Affect Disord, 129(1): 14-26. [Abstract] [Full-text]
131. The impact of drug use in social networks of patients with substance use and bipolar disorders.
     Am J Addict, 20(2): 100-5. [Abstract] [Full-text]
132. Aerosolised antipsychotic assuages agitation: inhaled loxapine for agitation associated with schizophrenia or bipolar disorder.
     Int J Clin Pract, 65(3): 330-40. [Abstract] [Full-text]
133. CTLA-4 confers a risk of recurrent schizophrenia, major depressive disorder and bipolar disorder in the Chinese Han population.
     Brain Behav Immun, 25(3): 429-33. [Abstract] [Full-text]
134. Paliperidone extended-release as adjunctive therapy to lithium or valproate in the treatment of acute mania: a randomized, placebo-controlled study.
     J Affect Disord, 129(1): 252-60. [Abstract] [Full-text]
135. Prolidase activity and its diagnostic performance in bipolar disorder.
     J Affect Disord, 129(1): 84-6. [Abstract] [Full-text]
136. Diet quality in bipolar disorder in a population-based sample of women.
     J Affect Disord, 129(1): 332-7. [Abstract] [Full-text]
137. Self-stigma, empowerment and perceived discrimination among people with bipolar disorder or depression in 13 European countries: the GAMIAN-Europe study.
     J Affect Disord, 129(1): 56-63. [Abstract] [Full-text]
138. Binge eating disorder and menstrual cycle in unmedicated women with bipolar disorder.
     J Affect Disord, 129(1): 75-8. [Abstract] [Full-text]
139. Correlates of first-episode polarity in a French cohort of 1089 bipolar I disorder patients: role of temperaments and triggering events.
     J Affect Disord, 129(1): 39-46. [Abstract] [Full-text]
140. Double-blind, randomized, placebo-controlled 6-week study on the efficacy and safety of the tamoxifen adjunctive to lithium in acute bipolar mania.
     J Affect Disord, 129(1): 327-31. [Abstract] [Full-text]
141. Long-term naturalistic follow-up of lithium augmentation: relevance to bipolarity.
     J Affect Disord, 129(1): 64-7. [Abstract] [Full-text]
142. Bipolar disorder patients have similar levels of education but lower socio-economic status than the general population.
     J Affect Disord, 129(1): 68-74. [Abstract] [Full-text]
143. Differential outcome of bipolar patients receiving antidepressant monotherapy versus combination with an antimanic drug.
     J Affect Disord, 129(1): 321-6. [Abstract] [Full-text]
144. N-acetyl cysteine add-on treatment for bipolar II disorder: a subgroup analysis of a randomized placebo-controlled trial.
     J Affect Disord, 129(1): 317-20. [Abstract] [Full-text]
145. Association of seasonality and premenstrual symptoms in Bipolar I and Bipolar II disorders.
     J Affect Disord, 129(1): 313-6. [Abstract] [Full-text]
146. Cyclothymic and hyperthymic temperaments may predict bipolarity in major depressive disorder: a supportive evidence for bipolar II1/2 and IV.
     J Affect Disord, 129(1): 34-8. [Abstract] [Full-text]
147. New treatment guidelines for acute bipolar depression: a systematic review.
     J Affect Disord, 129(1): 14-26. [Abstract] [Full-text]
148. New structural brain imaging endophenotype in bipolar disorder.
     Mol Psychiatry. [Abstract] [Full-text]
149. Pilot Study of Group Cognitive Behaviour Therapy for Heterogeneous Acute Psychiatric Inpatients: Treatment in a Sole-Standalone Session Allowing Patients to Choose the Therapeutic Target.
     Behav Cogn Psychother. [Abstract] [Full-text]
150. Association of clinical symptoms and neurocognitive performance in bipolar disorder: a longitudinal study.
     Bipolar Disord, 13(1): 118-23. [Abstract] [Full-text]
151. Paced finger-tapping abnormalities in bipolar disorder indicate timing dysfunction.
     Bipolar Disord, 13(1): 99-110. [Abstract] [Full-text]
152. Does stage of illness impact treatment response in bipolar disorder? Empirical treatment data and their implication for the staging model and early intervention.
     Bipolar Disord, 13(1): 87-98. [Abstract] [Full-text]
153. Suicidality in pediatric bipolar disorder: predictor or outcome of family processes and mixed mood presentation?
     Bipolar Disord, 13(1): 76-86. [Abstract] [Full-text]
154. Early psychosocial intervention for youth at risk for bipolar I or II disorder: a one-year treatment development trial.
     Bipolar Disord, 13(1): 67-75. [Abstract] [Full-text]
155. Pain and rejection sensitivity in bipolar depression.
     Bipolar Disord, 13(1): 59-66. [Abstract] [Full-text]
156. Markers of gluten sensitivity and celiac disease in bipolar disorder.
     Bipolar Disord, 13(1): 52-8. [Abstract] [Full-text]
157. Bcl-2 SNP rs956572 associates with disrupted intracellular calcium homeostasis in bipolar I disorder.
     Bipolar Disord, 13(1): 41-51. [Abstract] [Full-text]
158. A population-based morphometric MRI study in patients with first-episode psychotic bipolar disorder: comparison with geographically matched healthy controls and major depressive disorder subjects.
     Bipolar Disord, 13(1): 28-40. [Abstract] [Full-text]
159. Structural brain and neuropsychometric changes associated with pediatric bipolar disorder with psychosis.
     Bipolar Disord, 13(1): 16-27. [Abstract] [Full-text]
160. A quantitative meta-analysis of fMRI studies in bipolar disorder.
     Bipolar Disord, 13(1): 1-15. [Abstract] [Full-text]
161. New structural brain imaging endophenotype in bipolar disorder.
     Mol Psychiatry. [Abstract] [Full-text]
162. Pilot Study of Group Cognitive Behaviour Therapy for Heterogeneous Acute Psychiatric Inpatients: Treatment in a Sole-Standalone Session Allowing Patients to Choose the Therapeutic Target.
     Behav Cogn Psychother. [Abstract] [Full-text]
163. Gender differences in the effect of early life trauma on hypothalamic-pituitary-adrenal axis functioning.
     Depress Anxiety. [Abstract] [Full-text]
164. Substance Use and HIV Risk in a Sample of Severely Mentally Ill Puerto Rican Women.
     J Immigr Minor Health. [Abstract] [Full-text]
165. A task shifting approach to primary mental health care for adults in South Africa: human resource requirements and costs for rural settings.
     Health Policy Plan. [Abstract] [Full-text]
166. Longitudinal Follow-Up of Bipolar Disorder in Women With Premenstrual Exacerbation: Findings From STEP-BD.
     Am J Psychiatry. [Abstract] [Full-text]
167. Bipolar disorder susceptibility region on chromosome 3q29 not confirmed in a case-control association study.
     World J Biol Psychiatry. [Abstract] [Full-text]
168. Asenapine: a review of its use in the management of mania in adults with bipolar I disorder.
     CNS Drugs, 25(3): 251-67. [Abstract] [Full-text]
169. The physiology, signaling, and pharmacology of dopamine receptors.
     Pharmacol Rev, 63(1): 182-217. [Abstract] [Full-text]
170. Elevation of cerebrospinal fluid interleukin-1ß in bipolar disorder.
     J Psychiatry Neurosci, 36(2): 114-8. [Abstract] [Full-text]
171. N-acetylcysteine in psychiatry: current therapeutic evidence and potential mechanisms of action.
     J Psychiatry Neurosci, 36(2): 78-86. [Abstract] [Full-text]
172. Asenapine: a review of its use in the management of mania in adults with bipolar I disorder.
     CNS Drugs, 25(3): 251-67. [Abstract] [Full-text]
173. The physiology, signaling, and pharmacology of dopamine receptors.
     Pharmacol Rev, 63(1): 182-217. [Abstract] [Full-text]
174. Elevation of cerebrospinal fluid interleukin-1ß in bipolar disorder.
     J Psychiatry Neurosci, 36(2): 114-8. [Abstract] [Full-text]
175. N-acetylcysteine in psychiatry: current therapeutic evidence and potential mechanisms of action.
     J Psychiatry Neurosci, 36(2): 78-86. [Abstract] [Full-text]
176. Rates and Correlates of Pathological Gambling Among VA Mental Health Service Users.
     J Gambl Stud. [Abstract] [Full-text]
177. An epidemiologic and clinical overview of medical and psychopathological comorbidities in major psychoses.
     Eur Arch Psychiatry Clin Neurosci. [Abstract] [Full-text]
178. Olanzapine-induced parkinsonism associated with smoking cessation.
     Am J Health Syst Pharm, 68(5): 399-401. [Abstract] [Full-text]
179. Elevated daytime cortisol levels: A biomarker of subsequent major affective disorder?
     J Affect Disord. [Abstract] [Full-text]
180. Molecular pathways involved in neuronal cell adhesion and membrane scaffolding contribute to schizophrenia and bipolar disorder susceptibility.
     Mol Psychiatry, 16(3): 286-292. [Abstract] [Full-text]
181. Olanzapine-induced parkinsonism associated with smoking cessation.
     Am J Health Syst Pharm, 68(5): 399-401. [Abstract] [Full-text]
182. Molecular pathways involved in neuronal cell adhesion and membrane scaffolding contribute to schizophrenia and bipolar disorder susceptibility.
     Mol Psychiatry, 16(3): 286-92. [Abstract] [Full-text]
183. Evolution of promoter affinity for transcription factors in the human lineage.
     Mol Biol Evol. [Abstract] [Full-text]
184. A randomised controlled trial of carer-focussed multi-family group psychoeducation in bipolar disorder.
     Eur Psychiatry. [Abstract] [Full-text]
185. Pediatric bipolar disorder in a Spanish sample: Results after 2.6years of follow-up.
     J Affect Disord. [Abstract] [Full-text]
186. Drug safety evaluation of ziprasidone.
     Expert Opin Drug Saf. [Abstract] [Full-text]
187. Titanium alloys as fixation device material for cranioplasty and its safety in electroconvulsive therapy.
     J ECT, 27(1): e27-8. [Abstract] [Full-text]
188. Complicated management of mania in the setting of undiagnosed obstructive sleep apnea.
     J ECT, 27(1): e15-6. [Abstract] [Full-text]
189. Titanium alloys as fixation device material for cranioplasty and its safety in electroconvulsive therapy.
     J ECT, 27(1): e27-8. [Abstract] [Full-text]
190. Complicated management of mania in the setting of undiagnosed obstructive sleep apnea.
     J ECT, 27(1): e15-6. [Abstract] [Full-text]
191. Enhancement of temozolomide-induced apoptosis by valproic acid in human glioma cell lines through redox regulation.
     J Mol Med, 89(3): 303-15. [Abstract] [Full-text]
192. ZNF804A may be associated with executive control of attention.
     Genes Brain Behav, 10(2): 223-7. [Abstract] [Full-text]
193. Enhancement of temozolomide-induced apoptosis by valproic acid in human glioma cell lines through redox regulation.
     J Mol Med, 89(3): 303-15. [Abstract] [Full-text]
194. Serum brain-derived neurotrophic factor and clozapine daily dose in patients with schizophrenia: a positive correlation.
     Neurosci Lett, 491(3): 207-10. [Abstract] [Full-text]
195. ZNF804A may be associated with executive control of attention.
     Genes Brain Behav, 10(2): 223-7. [Abstract] [Full-text]
196. Serum brain-derived neurotrophic factor and clozapine daily dose in patients with schizophrenia: a positive correlation.
     Neurosci Lett, 491(3): 207-10. [Abstract] [Full-text]
197. Serum brain-derived neurotrophic factor and clozapine daily dose in patients with schizophrenia: a positive correlation.
     Neurosci Lett, 491(3): 207-10. [Abstract] [Full-text]
198. A 48-Year-Old Woman Primigravid via In Vitro Fertilization With Severe Bipolar Depression and Preeclampsia Treated Successfully With Electroconvulsive Therapy.
     J ECT, 27(1): e1-3. [Abstract] [Full-text]
199. Family psychoeducation for major depression: randomised controlled trial.
     Br J Psychiatry. [Abstract] [Full-text]
200. Screening for Malingering/Exaggeration of Psychiatric Symptomatology in Prison Inmates Using the PICTS Confusion and Infrequency Scales*.
     J Forensic Sci, 56(2): 444-9. [Abstract] [Full-text]
201. A 48-year-old woman primigravid via in vitro fertilization with severe bipolar depression and preeclampsia treated successfully with electroconvulsive therapy.
     J ECT, 27(1): e1-3. [Abstract] [Full-text]
202. Family psychoeducation for major depression: randomised controlled trial.
     Br J Psychiatry. [Abstract] [Full-text]
203. Screening for malingering/exaggeration of psychiatric symptomatology in prison inmates using the PICTS Confusion and Infrequency scales.
     J Forensic Sci, 56(2): 444-9. [Abstract] [Full-text]
204. Bipolar affective disorder, type II, apparently precipitated by donepezil.
     Int Psychogeriatr, 23(3): 503-4. [Abstract] [Full-text]
205. Bipolar affective disorder, type II, apparently precipitated by donepezil.
     Int Psychogeriatr, 23(3): 503-4. [Abstract] [Full-text]
206. Bipolar affective disorder, type II, apparently precipitated by donepezil.
     Int Psychogeriatr, 23(3): 503-4. [Abstract] [Full-text]
207. Prevalence and clinical impact of childhood trauma in patients with severe mental disorders.
     J Nerv Ment Dis, 199(3): 156-61. [Abstract] [Full-text]
208. Review of atypical antipsychotics in anxiety.
     Eur Neuropsychopharmacol. [Abstract] [Full-text]
209. Prevalence and clinical impact of childhood trauma in patients with severe mental disorders.
     J Nerv Ment Dis, 199(3): 156-61. [Abstract] [Full-text]
210. Review of atypical antipsychotics in anxiety.
     Eur Neuropsychopharmacol. [Abstract] [Full-text]
211. The impact of the Val158Met catechol-O-methyltransferase genotype on neural correlates of sad facial affect processing in patients with bipolar disorder and their relatives.
     Psychol Med, 41(4): 779-88. [Abstract] [Full-text]
212. The impact of the Val158Met catechol-O-methyltransferase genotype on neural correlates of sad facial affect processing in patients with bipolar disorder and their relatives.
     Psychol Med, 41(4): 779-88. [Abstract] [Full-text]
213. The impact of the Val158Met catechol-O-methyltransferase genotype on neural correlates of sad facial affect processing in patients with bipolar disorder and their relatives.
     Psychol Med, 41(4): 779-88. [Abstract] [Full-text]
214. From items to syndromes in the Hypomania Checklist (HCL-32): Psychometric validation and clinical validity analysis.
     J Affect Disord. [Abstract] [Full-text]
215. Altered sirtuin deacetylase gene expression in patients with a mood disorder.
     J Psychiatr Res. [Abstract] [Full-text]
216. Genetics in psychiatry: Are the promises met?
     World J Biol Psychiatry, 12(2): 81-8. [Abstract] [Full-text]
217. From items to syndromes in the Hypomania Checklist (HCL-32): Psychometric validation and clinical validity analysis.
     J Affect Disord. [Abstract] [Full-text]
218. Altered sirtuin deacetylase gene expression in patients with a mood disorder.
     J Psychiatr Res. [Abstract] [Full-text]
219. Genetics in psychiatry: are the promises met?
     World J Biol Psychiatry, 12(2): 81-8. [Abstract] [Full-text]
220. Is the lack of association between cognitive complaints and objective cognitive functioning in patients with bipolar disorder moderated by depressive symptoms?
     J Affect Disord. [Abstract] [Full-text]
221. Longitudinal changes in brain structure following the first episode of psychosis.
     Psychiatry Res, 191(3): 166-73. [Abstract] [Full-text]
222. Histone deacetylases in skeletal development and bone mass maintenance.
     Gene, 474(1): 1-11. [Abstract] [Full-text]
223. Antidepressant discontinuation manic states: a critical review of the literature and suggested diagnostic criteria.
     J Psychopharmacol, 25(3): 306-13. [Abstract] [Full-text]
224. Longitudinal changes in brain structure following the first episode of psychosis.
     Psychiatry Res, 191(3): 166-73. [Abstract] [Full-text]
225. Histone deacetylases in skeletal development and bone mass maintenance.
     Gene, 474(1): 1-11. [Abstract] [Full-text]
226. Impact of executive function deficits in youth with bipolar I disorder: a controlled study.
     Psychiatry Res, 186(1): 58-64. [Abstract] [Full-text]
227. Bipolar disorder and polymorphisms of glutathione S-transferases M1 (GSTM1) and T1 (GSTT1).
     Psychiatry Res, 186(1): 144-6. [Abstract] [Full-text]
228. Antidepressant discontinuation manic states: a critical review of the literature and suggested diagnostic criteria.
     J Psychopharmacol, 25(3): 306-13. [Abstract] [Full-text]
229. Longitudinal changes in brain structure following the first episode of psychosis.
     Psychiatry Res, 191(3): 166-73. [Abstract] [Full-text]
230. Histone deacetylases in skeletal development and bone mass maintenance.
     Gene, 474(1): 1-11. [Abstract] [Full-text]
231. Impact of executive function deficits in youth with bipolar I disorder: a controlled study.
     Psychiatry Res, 186(1): 58-64. [Abstract] [Full-text]
232. Bipolar disorder and polymorphisms of glutathione S-transferases M1 (GSTM1) and T1 (GSTT1).
     Psychiatry Res, 186(1): 144-6. [Abstract] [Full-text]
233. Validation of the revised Problems Assessment for Substance Using Psychiatric Patients.
     Addict Behav, 36(5): 494-501. [Abstract] [Full-text]
234. Longitudinal changes in brain structure following the first episode of psychosis.
     Psychiatry Res, 191(3): 166-73. [Abstract] [Full-text]
235. Impact of executive function deficits in youth with bipolar I disorder: a controlled study.
     Psychiatry Res, 186(1): 58-64. [Abstract] [Full-text]
236. Bipolar disorder and polymorphisms of glutathione S-transferases M1 (GSTM1) and T1 (GSTT1).
     Psychiatry Res, 186(1): 144-6. [Abstract] [Full-text]
237. Validation of the revised Problems Assessment for Substance Using Psychiatric Patients.
     Addict Behav, 36(5): 494-501. [Abstract] [Full-text]

© 2004-2013 Bipolar Research Today. All Rights Reserved.